79
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Circ_0031242 Silencing Mitigates the Progression and Drug Resistance in DDP-Resistant Hepatoma Cells by the miR-924/POU3F2 Axis

, , &
Pages 743-755 | Published online: 26 Jan 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chenxi Xie, Xiaopei Hao, Hao Yuan, Chongyu Wang, Razinah Sharif & Haibo Yu. (2024) Crosstalk Between circRNA and Tumor Microenvironment of Hepatocellular Carcinoma: Mechanism, Function and Applications. OncoTargets and Therapy 17, pages 7-26.
Read now

Articles from other publishers (12)

Guocheng Rao, Xi Peng, Yan Tian, Xianghui Fu & Yuwei Zhang. (2023) Circular RNAs in hepatocellular carcinoma: biogenesis, function, and pathology. Frontiers in Genetics 14.
Crossref
Sadra Samavarchi Tehrani, Fataneh Esmaeili, Moein Shirzad, Golnaz Goodarzi, Tooba Yousefi, Mahmood Maniati, Mortaza Taheri‐Anganeh & Amir Anushiravani. (2023) The critical role of circular RNAs in drug resistance in gastrointestinal cancers. Medical Oncology 40:4.
Crossref
Zheng Liu, Fangming Yang, Zhun Xiao & Yuexuan Liu. (2023) Review of novel functions and implications of circular RNAs in hepatocellular carcinoma. Frontiers in Oncology 13.
Crossref
Cheng Wang, Honglin Zhou, Rui Wu, Yuqin Guo, Lihong Gong, Ke Fu, Cheng Ma, Cheng Peng & Yunxia Li. (2023) Mesenchymal stem cell-derived exosomes and non-coding RNAs: Regulatory and therapeutic role in liver diseases. Biomedicine & Pharmacotherapy 157, pages 114040.
Crossref
Xinxin Chen, Jin Li, Yuhong Huang & Chao Liang. 2023. Hepatobiliary Cancers: An Interdisciplinary Approach. Hepatobiliary Cancers: An Interdisciplinary Approach 325 348 .
Zhao-Shan Niu & Wen-Hong Wang. (2022) Circular RNAs in hepatocellular carcinoma: Recent advances. World Journal of Gastrointestinal Oncology 14:6, pages 1067-1085.
Crossref
Song Wang, Long Qian, Tingting Cao, Li Xu, Yan Jin, Hao Hu, Qingsheng Fu, Qian Li, Ye Wang, Jiawei Wang, Yabin Xia & Xiaoxu Huang. (2022) Advances in the Study of CircRNAs in Tumor Drug Resistance. Frontiers in Oncology 12.
Crossref
Qinfu Xu, Jiang Shi, Long Zhang, Yanbing Sheng, Yang Zhang, Dan Chu & Aiguo Xu. (2022) Circ_0006006 facilitates non‐small cell lung cancer progression by modulating miR‐924/SRSF7 axis. The Journal of Gene Medicine 24:5.
Crossref
Xu-feng Xu, Xiao-ke Yang, Yang Song, Bang-jie Chen, Xiao Yu, Tao Xu & Zhao-lin Chen. (2022) Dysregulation of non-coding RNAs mediates cisplatin resistance in hepatocellular carcinoma and therapeutic strategies. Pharmacological Research 176, pages 105906.
Crossref
Jie-Chun Lin, Nan-Xing Zhu & Ling-Fei Wu. (2021) Research progress of circRNAs in chemotherapy resistance of digestive system neoplasms. World Chinese Journal of Digestology 29:21, pages 1237-1247.
Crossref
Qingchun Mu, Yue Lv, Chunmei Luo, Xiaojing Liu, Chunming Huang, Youcheng Xiu & Longguang Tang. (2021) Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors. Frontiers in Pharmacology 12.
Crossref
Rui Liao, Lei Liu, Jian Zhou, Xufu Wei & Ping Huang. (2021) Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma. Frontiers in Oncology 11.
Crossref